Symptomatic exacerbation of Crohn disease after treatment with high-dose interleukin-2

Joseph A. Sparano; Lawrence J. Brandt; Janice P. Dutcher; Jon S. DuBois; Michael B. Atkins

Symptomatic exacerbation of Crohn disease after treatment with high-dose interleukin-2

Joseph A. Sparano, Lawrence J. Brandt, Janice P. Dutcher, Jon S. DuBois, Michael B. Atkins

Medicine

Research output: Contribution to journal › Article › peer-review

35 Scopus citations

Abstract

Two patients treated with high-dose interleukin-2 (IL-2), who had a history of Crohn disease that was clinically quiescent for 4 and 9 years before therapy, developed symptomatic reactivation of Crohn disease requiring surgical intervention.

Original language	English (US)
Pages (from-to)	617-618
Number of pages	2
Journal	Annals of internal medicine
Volume	118
Issue number	8
State	Published - Apr 15 1993

ASJC Scopus subject areas

Internal Medicine

Cite this

@article{0af0890458f64c518b95758fb68c98ce,

title = "Symptomatic exacerbation of Crohn disease after treatment with high-dose interleukin-2",

abstract = "Two patients treated with high-dose interleukin-2 (IL-2), who had a history of Crohn disease that was clinically quiescent for 4 and 9 years before therapy, developed symptomatic reactivation of Crohn disease requiring surgical intervention.",

author = "Sparano, {Joseph A.} and Brandt, {Lawrence J.} and Dutcher, {Janice P.} and DuBois, {Jon S.} and Atkins, {Michael B.}",

year = "1993",

month = apr,

day = "15",

language = "English (US)",

volume = "118",

pages = "617--618",

journal = "Annals of internal medicine",

issn = "0003-4819",

publisher = "American College of Physicians",

number = "8",

}

TY - JOUR

T1 - Symptomatic exacerbation of Crohn disease after treatment with high-dose interleukin-2

AU - Sparano, Joseph A.

AU - Brandt, Lawrence J.

AU - Dutcher, Janice P.

AU - DuBois, Jon S.

AU - Atkins, Michael B.

PY - 1993/4/15

Y1 - 1993/4/15

N2 - Two patients treated with high-dose interleukin-2 (IL-2), who had a history of Crohn disease that was clinically quiescent for 4 and 9 years before therapy, developed symptomatic reactivation of Crohn disease requiring surgical intervention.

AB - Two patients treated with high-dose interleukin-2 (IL-2), who had a history of Crohn disease that was clinically quiescent for 4 and 9 years before therapy, developed symptomatic reactivation of Crohn disease requiring surgical intervention.

UR - http://www.scopus.com/inward/record.url?scp=0027419329&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027419329&partnerID=8YFLogxK

M3 - Article

C2 - 8452327

AN - SCOPUS:0027419329

SN - 0003-4819

VL - 118

SP - 617

EP - 618

JO - Annals of internal medicine

JF - Annals of internal medicine

IS - 8

ER -

Symptomatic exacerbation of Crohn disease after treatment with high-dose interleukin-2

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this